New patent expiration for Wyeth Pharms drug DUAVEE
Annual Drug Patent Expirations for DUAVEE Duavee is a drug marketed by Wyeth Pharms and is included in one NDA. […]
New patent expiration for Wyeth Pharms drug DUAVEE Read Post »
Patent Expiration
New patent expiration for APGDI drug MYRBETRIQ GRANULES
Annual Drug Patent Expirations for MYRBETRIQ+GRANULES Myrbetriq Granules is a drug marketed by Apgdi and is included in one NDA.
New patent expiration for APGDI drug MYRBETRIQ GRANULES Read Post »
New patent expiration for APGDI drug MYRBETRIQ
Annual Drug Patent Expirations for MYRBETRIQ Myrbetriq is a drug marketed by Apgdi and is included in two NDAs. It
Drug Patent Expirations for the Week of April 28, 2024
MYRBETRIQ GRANULES (mirabegron) Apgdi Patent: 7,982,049 Expiration: May 4, 2024 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of April 28, 2024 Read Post »
New patent expiration for Abbvie drug DURYSTA
Annual Drug Patent Expirations for DURYSTA Durysta is a drug marketed by Abbvie and is included in one NDA. It
New patent expiration for Aveo Pharms drug FOTIVDA
Annual Drug Patent Expirations for FOTIVDA Fotivda is a drug marketed by Aveo Pharms and is included in one NDA.
New patent expiration for Aveo Pharms drug FOTIVDA Read Post »
New patent expiration for Titan Pharms drug PROBUPHINE
Annual Drug Patent Expirations for PROBUPHINE Probuphine is a drug marketed by Titan Pharms and is included in one NDA.
New patent expiration for Titan Pharms drug PROBUPHINE Read Post »
New patent expiration for Currax drug ONZETRA XSAIL
Annual Drug Patent Expirations for ONZETRA+XSAIL Onzetra Xsail is a drug marketed by Currax and is included in one NDA.
New patent expiration for Currax drug ONZETRA XSAIL Read Post »
New patent expiration for Horizon drug RAYOS
Annual Drug Patent Expirations for RAYOS Rayos is a drug marketed by Horizon and is included in one NDA. It
